ANALOGIFREMGANGSMADE TIL FREMSTILLING AF DIACYLOXY-BENZOESYREANILIDER

1280407 Diacyloxy-benzoic acid anilides FARBWERKE HOECHST AG 9 June 1970 [9 June 1969] 27829/70 Heading C2C Novel compounds of Formula I (in which X is H or halogen; R1 is 1 to 3 substituents selected from NO 2 , CF 3 and halogen; and R2 is H; C 1-6 alkyl which may be substituted by one or more halo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KONIG J, DYWEL D, RUSCHIG H
Format:	Patent
Sprache:	dan
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS BLASTING CHEMISTRY COMBUSTION APPARATUS COMBUSTION PROCESSES DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION EXTINGUISHING-DEVICES FODDER FOODS OR FOODSTUFFS HEATING HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE IGNITION LIGHTING MECHANICAL ENGINEERING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY OTHER DOMESTIC STOVES OR RANGES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES RANGES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES VENTILATING WEAPONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	1280407 Diacyloxy-benzoic acid anilides FARBWERKE HOECHST AG 9 June 1970 [9 June 1969] 27829/70 Heading C2C Novel compounds of Formula I (in which X is H or halogen; R1 is 1 to 3 substituents selected from NO 2 , CF 3 and halogen; and R2 is H; C 1-6 alkyl which may be substituted by one or more halogen atoms or a C 1-6 alkoxy or phenyl group; C 2-5 alkenyl; C 4-6 cycloalkyl; phenyl; an unsaturated 5- or 6- membered heterocyclic ring; C 1-4 alkylamino; di - (C 1-4 alkyl)amino ; pyrrolidino; piperidino ; morpholino; or 4-methylpiperazino) are prepared by acylating compounds of Formula II 5 - Iodo - 3 - nitro - 2,6 - dihydroxy - benzoic acid 41-chloroanilide is prepared by reacting 3- nitro - 2,6 - dihydroxy - benzoic acid 41- chloroanilide with iodine monochloride. Anthelmintic compositions for oral or parenteral administration, comprise a compound of Formula I together with a pharmaceutical carrier.